Chung Jane — SEC Form 4 filings

SEC reporting owner CIK 1872398. 14 Form 4 filings on record with FilingPulse; latest filed 2026-03-06.

Transaction summary — filings shown

Covers all 14 filings on record, filed 2024-03-05 to 2026-03-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
SUTRO BIOPHARMA, INC. (STRO)Chief Executive Officer, Director131 leg · 12,500 sh · $10,01143
Viracta Therapeutics, Inc. (VIRX)Director11

Form 4 filings — Chung Jane

FiledFormIssuerReported transactionsSource
2026-03-064SUTRO BIOPHARMA, INC. (STRO)Option exercise (M): 788 @ $0 · Tax withholding (F): 282 @ $21.31 · Option exercise (M): 788 (derivative) @ $0EDGAR
2026-03-034SUTRO BIOPHARMA, INC. (STRO)Option exercise (M): 688 @ $0 · Option exercise (M): 2,500 @ $0 · Tax withholding (F): 1,271 @ $20.47 · Option exercise (M): 7,750 @ $0 · Tax withholding (F): 2,779 @ $20.55 · Option exercise (M): 688 (derivative) @ $0 · +4 moreEDGAR
2025-12-164SUTRO BIOPHARMA, INC. (STRO)Option exercise (M): 2,500 @ $0 · Tax withholding (F): 894 @ $8.02 · Option exercise (M): 2,500 (derivative) @ $0EDGAR
2025-10-164SUTRO BIOPHARMA, INC. (STRO)Purchase (P): 12,500 @ $0.80EDGAR
2025-08-264SUTRO BIOPHARMA, INC. (STRO)Option exercise (M): 18,750 @ $0 · Tax withholding (F): 6,708 @ $0.80 · Option exercise (M): 18,750 (derivative) @ $0EDGAR
2025-04-084SUTRO BIOPHARMA, INC. (STRO)Grant/award (A): 620,000 (derivative) @ $0 · Grant/award (A): 310,000 (derivative) @ $0EDGAR
2025-03-064SUTRO BIOPHARMA, INC. (STRO)Option exercise (M): 7,875 @ $0 · Tax withholding (F): 2,334 @ $1.42 · Option exercise (M): 7,875 (derivative) @ $0EDGAR
2025-03-044SUTRO BIOPHARMA, INC. (STRO)Option exercise (M): 6,875 @ $0 · Option exercise (M): 25,000 @ $0 · Tax withholding (F): 9,450 @ $1.59 · Option exercise (M): 6,875 (derivative) @ $0 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2024-12-034SUTRO BIOPHARMA, INC. (STRO)Option exercise (M): 25,000 @ $0 · Tax withholding (F): 8,920 @ $2.69 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2024-08-134SUTRO BIOPHARMA, INC. (STRO)Option exercise (M): 18,750 @ $0 · Tax withholding (F): 6,689 @ $3.12 · Option exercise (M): 18,750 (derivative) @ $0EDGAR
2024-06-244Viracta Therapeutics, Inc. (VIRX)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2024-03-074SUTRO BIOPHARMA, INC. (STRO)Grant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2024-03-064SUTRO BIOPHARMA, INC. (STRO)Option exercise (M): 7,875 @ $0 · Tax withholding (F): 2,209 @ $4.79 · Option exercise (M): 7,875 (derivative) @ $0EDGAR
2024-03-054SUTRO BIOPHARMA, INC. (STRO)Option exercise (M): 6,875 @ $0 · Tax withholding (F): 2,038 @ $4.95 · Option exercise (M): 6,875 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1872398 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →